| 今开：12.85 | 昨收：12.85 |
| 最高：13.14 | 最低：12.38 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：6.19640052E8 |
医麦客06-21 07:30
2024年6月21日
医麦客新闻 eMedClub News
近日，REGENXBIO宣布成功完成了RGX-121治疗黏多糖贮积症II型（MPS II）的生物制剂许可申请前（BLA）会议，并与美国FDA敲定了BLA的细节。
FDA继续同意REGENXBIO的计划，使用脑脊液（CSF）硫酸乙酰肝素D2S6水平（脑部疾病活动的关键生物标志...查看全文
Regenxbio(RGNX)06-05 04:45
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004653 Size: 7 KB 网页链接查看全文
Regenxbio(RGNX)05-15 04:25
$Regenxbio(RGNX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003648 Act: 33 Size: 6 KB 网页链接查看全文
Regenxbio(RGNX)06-04 04:45
$Regenxbio(RGNX)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0000950170-24-068050 Act: 34 Size: 162 KB 网页链接查看全文
Regenxbio(RGNX)06-05 04:45
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004656 Size: 7 KB 网页链接查看全文
Regenxbio(RGNX)06-05 04:45
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004654 Size: 7 KB 网页链接查看全文
Regenxbio(RGNX)07-03 20:05
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005566 Size: 9 KB 网页链接查看全文
Regenxbio(RGNX)07-19 05:15
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005798 Size: 14 KB 网页链接查看全文
Regenxbio(RGNX)05-17 05:15
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004104 Size: 9 KB 网页链接查看全文
Regenxbio(RGNX)06-05 04:45
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004652 Size: 7 KB 网页链接查看全文
蹊之美股生物医药2018-06-03 13:47
$Abeona Therapeutics Inc.(ABEO)$ $bluebird bio(BLUE)$ $$REGENXBIO Inc.(RGNX)$查看全文
蹊之美股生物医药2018-06-03 13:09
$Abeona Therapeutics Inc.(ABEO)$ $bluebird bio(BLUE)$$REGENXBIO Inc.(RGNX)$@今日话题 @雪盈证券
纳斯达克生物科技公司长文分析——基因治疗公司系列（二）
作者：格格；
微信公众号：蹊之美股生物医药；
雪球号：Caesar_Biotech；
主要公司：Abeona Therapeutics(NASDA...查看全文
usbiostock2018-05-02 22:46
$REGENXBIO Inc.(RGNX)$ FDA授予RGX-121基因疗法“快速通道”地位，用以治疗粘多糖沉积症2 型。公司预计在2018年中期开始患者招募。查看全文
淘沙见金2018-01-31 11:32
网页链接 这篇评论文章值得一读，里面提到了James Wilson团队研究的几个不足之处：First, the number of animals included in the work was small. Second, the vector they use is research grade, not clinical grade. Finally, they use AAV...查看全文
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005798 Size: 14 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005566 Size: 9 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005567 Size: 8 KB 网页链接
$Regenxbio(RGNX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005142 Act: 33 Size: 5 KB 网页链接
$Regenxbio(RGNX)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001193125-24-160146 Act: 34 Size: 179 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004649 Size: 7 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004650 Size: 7 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004651 Size: 10 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004652 Size: 7 KB 网页链接
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-004653 Size: 7 KB 网页链接